Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function - Contacts and Locations

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

This study has been completed.

Study NCT00002901. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002901

Locations


United States, California
	Cancer Center and Beckman Research Institute, City of Hope
	Duarte, California, United States, 91010-3000
	University of California Davis Cancer Center
	Sacramento, California, United States, 95817
	USC/Norris Comprehensive Cancer Center and Hospital
	Los Angeles, California, United States, 90033-0804

Sponsors and Collaborators

Beckman Research Institute

National Cancer Institute (NCI)

Investigators


Study Chair:	James H. Doroshow, MD	Beckman Research Institute